Arrowsmith Oncology LLC Bainbridge Island, WA - 98110

Arrowsmith Oncology LLC is categorized under Oncologists in Bainbridge Island, WA and active since 2007.

Arrowsmith Oncology LLC was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Robert Earhart at the company’s single location by writing to 13098 Manzanita Road Ne, Bainbridge Island, Washington WA 98110 or by phoning (206) 780-2008. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Arrowsmith Oncology LLC
Contact Person: Robert Earhart
Address: 13098 Manzanita Road Ne, Bainbridge Island, Washington 98110
Phone Number: (206) 780-2008
Website Address: arrowsmithoncology.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Oncologists
SIC Code: 8011
NAICS Code: 6214930
Share This Business:

Arrowsmith Oncology LLC was started in 2007 to provide professional Oncologists under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Robert Earhart for inquiries that concern Arrowsmith Oncology LLC by calling the company number (206) 780-2008, as your correspondence is most welcome. Additionally, the physical location of the single location of Arrowsmith Oncology LLC can be found at the coordinates 47.681318,-122.561 as well as the street address 13098 Manzanita Road Ne in Bainbridge Island, Washington 98110.

For its online presence, you may visit Arrowsmith Oncology LLC’s website at arrowsmithoncology.com and engage with its social media outlets through on Twitter and on Facebook.